Faced with a recent slowdown in much of the contract research organization (CRO) industry, Ricerca Biosciences LLC has tweaked its focus to solidify its future. The Concord Township, Ohio-based company has shaken up its client base to include more pharmaceutical firms and is growing its Asian operations to take advantage of the increasingly lucrative market.
Contract drug-development organization Ricerca Biosciences LLC is offering a new service that compares drug candidates to a large reference set of pharmacologically active compounds. The new service, called Foresight, helps predict in vivo effects from in vitro drug data and provides insight into additional compound activities, according to a statement from Concord Township, Ohio-based Ricerca. […]
Contract drug development organization Ricerca Biosciences LLC has agreed to acquire the discovery and preclinical business of MDS Pharma Services for $35 million less working capital and cap-ex reserve.
Biomedical companies with compelling technologies could win millions of dollars in investments this year despite the worst gloom in financial markets since the Great Depression.
